The International Integrative Innovative Immunology for Myelodysplastic Neoplasms consortium—also known as ‘i4MDS’—held its second general meeting in The Hague from February 9–10, 2024. Organized by EHA and sponsorship partner Beckman Coulter, the event saw 52 participants from 27 European and US centers come together to discuss recent findings. Attendees also used the general meeting as an opportunity to brainstorm the next consortium’s next steps—including possible grant applications.
GenoMed4All was represented by Prof. Matteo Della Porta from Humanitas Research Center, who delivered a talk on the role of AI in hemato-oncology, sharing insights into the use of synthetic data in translational research and its potential clinical applications.
